The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in income, its exclusivity period created a here deluge of generic competition , significantly diminishing its dominance. While certain pharmaceutical companies may try to capitalize on related treatments ,